Compugen

Immuno-oncology company with propreitary in-silico drug discovery platform

placeHolon, Tel Aviv District, Israel calendar_todayFounded 1993 groups20 employees language cgen.com

Innovation

109 patent families (43 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 16,038 times.

YearFilings
201517
201617
201715
20187
20199
202012
202111
202216
202315
202414
20259
20266

Social engagement

Social engagement: 8.9K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Apax, Pequot Capital Management, Clal Biotechnology Industries, State Farm.

Investor typeCountShare
Venture capital758%
Private equity18%
Other / undisclosed433%

Recent activity

8 Jun 2026
Event
Josey fireside chat series on AI in drug development
19 May 2026
Event
fireside chat with Stifel Financial Corp. analyst Stephen Willey
13 Apr 2026
Event
25th Annual Needham Virtual Healthcare Conference
Coming soon